Skip to Main Content

REPRESENTATIVE EXPERIENCE

Kelvin Kesse

Represented a commercial-stage biotech company in its US$345 million initial public offering.
Served as U.S. counsel for a producer of infant milk formula in its global offering.
Represented a Canadian mining company in its acquisition of mines in the United States pursuant to a plan of arrangement for US$460 million, and in a US$100 million offering in connection therewith.
Represented the selling shareholders in a US$645.3 million follow-on equity offering, including US$252.7 million in shares offered by such selling shareholders.
Represented a Canadian company in its MJDS shelf takedown offering of $44 million and its listing on a U.S. Stock Exchange concurrently therewith.
Represented a life sciences company in its follow-on equity offering of US$40 million.
Represented the operator of an integrated holographic AR application platform in its initial public offering.
Routinely represent various domestic companies and Foreign Private Issuers with registration of securities under the ’33 Act, SEC reporting and/or matters arising in connection therewith, and general corporate governance.
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel